Debridement (Sharp, Enzymatic, Autolytic)
Treatment for Decubitus Ulcer
Typical Dosage: As per method (e.g., surgical procedure, daily enzyme application)
Effectiveness
88%
Safety Score
85%
Clinical Trials
200
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
85
DangerousModerateSafe
Treatment Details
Dosage Range
As per method (e.g., surgical procedure, daily enzyme application)
Time to Effect
Immediate removal of necrotic tissue, promotes healing over days-weeks
Treatment Duration
Repeated as needed until wound bed is clean
Evidence Quality
HIGHNumber Needed to Harm (NNH)
50(Treat 50 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$300
Side Effect Mgmt:$200
Total Annual:$500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
0.3
Outcome-Based Costs
Cost per Responder
$1,764.71
Cost per Remission
$2,500
Debridement (Sharp, Enzymatic, Autolytic) Outcomes
for Decubitus Ulcer
Efficacy Outcomes
Overall Effectiveness
+88%
Response Rate
+85%
Remission Rate
+60%
Common Side Effects
Pain (sharp debridement)
+25%
Bleeding (sharp debridement)
+5%
Skin irritation (enzymatic debridement)
+3%
Infection
+2%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov